Treatment of vestibular migraines is very similar to that of regular migraine headaches. Acute treatment involves non-steroidal anti-inflammatory agents (NSAIDs), like ibuprofen or naproxen, and, in severe cases, triptans like sumatriptan, zolmitriptan, or rizatriptan. These medications act on the initiating mechanisms of migraine, so they work best if used at the first sign of a migraine attack. Vestibular suppressants, like benzodiazepines (e.g., diazepam) or antihistamines (e.g., dimenhydrinate), may also be prescribed to relieve vertigo symptoms, particularly during acute episodes.
People who have multiple episodes of migraines can benefit from preventive treatment. Treatment options include beta-blockers, like propranolol, timolol, or metoprolol; calcium-channel blockers, like verapamil or flunarizine; tricyclic antidepressants, like amitriptyline; and some anti-epileptic medications, like topiramate.
Another treatment is onabotulinum toxin A, more commonly known as Botox, which is injected into the head and neck muscles every few months. Finally, there is a new class of medications called anti-CGRP antibodies (e.g., erenumab, fremanezumab, and galcanezumab), which target the calcitonin gene-related peptide, or its receptor, reducing pain transmission through the trigeminal pathway.
In addition to pharmacological treatment, people with vestibular migraines may benefit from vestibular rehabilitation, a form of physical therapy aimed at improving balance, reducing dizzy spells, and developing compensatory mechanisms in the vestibular system. Newer therapies, like vagal nerve stimulation, are currently being researched to treat migraine-associated vertigo. While it is still an experimental treatment, it is thought that stimulation of the vagus nerve could influence the release of neurotransmitters in the nervous system, thereby regulating pain perception.